Illumina Inc (ILMN)
130.12
-2.15
(-1.63%)
USD |
NASDAQ |
Sep 27, 16:00
130.10
-0.02
(-0.02%)
After-Hours: 20:00
Illumina Research and Development Expense (Annual): 1.354B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.354B |
December 31, 2022 | 1.321B |
December 31, 2021 | 1.185B |
December 31, 2020 | 682.00M |
December 31, 2019 | 647.00M |
December 31, 2018 | 623.00M |
December 31, 2017 | 546.00M |
December 31, 2016 | 504.00M |
December 31, 2015 | 401.00M |
December 31, 2014 | 388.06M |
December 31, 2013 | 276.74M |
December 31, 2012 | 231.02M |
December 31, 2011 | 196.91M |
Date | Value |
---|---|
December 31, 2010 | 177.95M |
December 31, 2009 | 140.62M |
December 31, 2008 | 99.96M |
December 31, 2007 | 73.94M |
December 31, 2006 | 33.37M |
December 31, 2005 | 27.72M |
December 31, 2004 | 21.11M |
December 31, 2003 | 22.51M |
December 31, 2002 | 26.85M |
December 31, 2001 | 20.74M |
December 31, 2000 | 13.55M |
December 31, 1999 | 4.086M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
647.00M
Minimum
2019
1.354B
Maximum
2023
1.038B
Average
1.185B
Median
2021
Research and Development Expense (Annual) Benchmarks
Waters Corp | 174.94M |
Exact Sciences Corp | 425.88M |
Mettler-Toledo International Inc | 185.28M |
Guardant Health Inc | 367.19M |
Natera Inc | 320.68M |